![]() | License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version (722kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-527311
- DOI to cite this document:
- 10.5283/epub.52731
Abstract
Background To date, in-depth analysis of leukapheresis products as starting material for CAR T-cell manufacturing, specifically Tisagenlecleucel production, are scarce. In this study, we report on lymphapheresis data for production of Tisagenlecleucel for elderly and pretreated lymphoma patients. Study Design and Methods Spectra Optia from Terumo BCT, Lakewood, CO, was employed for apheresis ...

Owner only: item control page